Millions of people have turned to GLP-1 drugs like Ozempic and Wegovy expecting dramatic results. Most get them. But for roughly one in ten patients, the needle barely moves: blood sugar stays ...
Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that revolutionized diabetes and weight loss did not slow the disease’s ...
SAN DIEGO Dec 2 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab in 2020 launched pivotal trials of its GLP-1 drug semaglutide in Alzheimer's patients based on studies in humans, animals and ...
We preselected all newsletters you had before unsubscribing.
Two of the largest clinical trials of their kind have doused hopes that a diabetes and weight loss “wonder drug” might also work its magic on Alzheimer’s. A daily dose of oral semaglutide did not ...
“Some patients literally told me that they felt that they were losing muscle or muscle was slipping away from them while they were on these medications,” said researcher Zhenqi Liu, MD, of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results